Zymewire Blog

Exploring the frontiers of biotech & pharma.

Join us as we dive into the sea of emerging biotechs, discuss industry news and the implications they have on providers to biopharma (CROs, CDMOs, eClinical, etc.), and tips for prospecting within the everchanging world of life sciences. 

OUR LATEST

Zymewire Blog

Why Your Cold Outreach to Biotechs (Still) isn't Working: A Battle with AI

06 Mar, 2024
Goals & Hurdles Read More
Rectangle 10

Subscribe Now
Rectangle 10

Recent Posts

Discovering Biotech Startups: A map for Selling to Quartz Therapeutics
Discovering Biotech Startups: A map for Selling to Quartz Therapeutics
13 Nov, 2019
Industry Articles
by David Wilkerson

We are moving right along with the new branch of the Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology ...

Read More
Discovering Biotech Startups: A map for Selling to KayoThera
Discovering Biotech Startups: A map for Selling to KayoThera
30 Oct, 2019
Industry Articles
by David Wilkerson

We are going right along with the new branch of the Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology companies ...

Read More
Discovering Biotech Startups: A map for Selling to Abtelum Biomedical
Discovering Biotech Startups: A map for Selling to Abtelum Biomedical
25 Oct, 2019
Industry Articles
by David Wilkerson

We are going right along with the new branch of the Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology companies ...

Read More
Discovering Biotech Startups: A map for Selling to Scopus Biopharma
Discovering Biotech Startups: A map for Selling to Scopus Biopharma
21 Oct, 2019
Industry Articles
by David Wilkerson

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
Discovering Biotech Startups: A map for Selling to Vitalex Biosciences
Discovering Biotech Startups: A map for Selling to Vitalex Biosciences
15 Oct, 2019
Industry Articles
by David Wilkerson

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
What has your CRM done for you lately?
What has your CRM done for you lately?
15 Oct, 2019
Industry Articles
by Ty Quinn

Guest post by Ty Quinn (CRO Business Development Executive):

Read More
Discovering Biotech Startups: A map for selling to Praxis Precision Medicines
Discovering Biotech Startups: A map for selling to Praxis Precision Medicines
15 Oct, 2019
Industry Articles
by David Wilkerson

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
CRIO Deals – Impact on Your Biotech Business Development Process
CRIO Deals – Impact on Your Biotech Business Development Process
15 Oct, 2019
Industry Articles
by Pete Bastedo

This article was originally published by Zymewire on 04/08/2015.

Read More
Discovering Biotech Startups: A map for Selling to BlueSphere Bio
Discovering Biotech Startups: A map for Selling to BlueSphere Bio
15 Oct, 2019
Industry Articles
by David Wilkerson

We’re adding a branch to our Sponsor Atlas series, which will focus on young pharmaceutical and biotechnology companies that are in early ...

Read More
Splurges & Sprees to kick off 2019
Splurges & Sprees to kick off 2019
15 Oct, 2019
Industry Articles
by Sean Cannon

Welcome to Zymewire’s newest blog series, Flagged Events: M&A, where we will be recapping some of the latest mergers & acquisition ...

Read More
February 2019 Buys
February 2019 Buys
15 Oct, 2019
Industry Articles
by Sean Cannon

Welcome back to Flagged Events: M&A, where we recap some of the latest mergers & acquisition activities across pharma for the month.

Read More
California Biotech Funding in August 2019
California Biotech Funding in August 2019
15 Oct, 2019
Industry Articles
by Sean Cannon

Welcome to the newest instalment of Flagged Events: Funding segment. We’ll cover a sample of the drug companies with funding announcements ...

Read More
Sponsor Pipeline Insights: The Most Active Drug Companies in New York
Sponsor Pipeline Insights: The Most Active Drug Companies in New York
15 Oct, 2019
Industry Articles
by Sean Cannon

We live in a time where lists make up much of the content that appears in our timelines each day. So, why not ride the wave? Everybody ...

Read More
Sponsor Pipeline Insights: The Most Active Drug Companies in the American Northeast
Sponsor Pipeline Insights: The Most Active Drug Companies in the American Northeast
15 Oct, 2019
Industry Articles
by Sean Cannon

For our latest edition of Sponsor Pipeline Insights, we’re taking a look at the Northeast USA. More specifically, we’re comparing sponsor ...

Read More
Coherus Biosciences' Outsourcing Strategy
Coherus Biosciences' Outsourcing Strategy
15 Oct, 2019
Industry Articles
by Pete Bastedo

Originally published by Zymewire on 09/28/2014.

Read More
Discovering Biotech Startups: A map for Selling to MedaRed
Discovering Biotech Startups: A map for Selling to MedaRed
15 Oct, 2019
Industry Articles
by David Wilkerson

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
Marketing vs. Sales: Their Major Difference and How They Work Together
Marketing vs. Sales: Their Major Difference and How They Work Together
15 Oct, 2019
Industry Articles
by Tenfold

This article is originally posted at Tenfold.com

Read More
Sponsor Pipeline Insights: The Most Active Drug Companies in France
Sponsor Pipeline Insights: The Most Active Drug Companies in France
15 Oct, 2019
Industry Articles
by Sean Cannon

In our 3rd edition of Sponsor Pipeline Insights, we’re heading overseas to France, a growing hotbed for clinical activity in Europe. While ...

Read More
From A to Z: A map for Selling to AstraZeneca
From A to Z: A map for Selling to AstraZeneca
15 Oct, 2019
Industry Articles
by Xhermi Trimi

AstraZeneca (AZ) is a biopharmaceutical company formed in 1999 following the merger two existing European international pharmaceutical ...

Read More
M&A in May 2019
M&A in May 2019
15 Oct, 2019
Industry Articles
by Sean Cannon

Welcome back to Flagged Events: M&A, where we recap some of the latest mergers & acquisition activities across pharma for the ...

Read More
Massachusetts Biotech Funding in July 2019
Massachusetts Biotech Funding in July 2019
15 Oct, 2019
Industry Articles
by Sean Cannon

Welcome to the newest instalment of Flagged Events: Funding segment. We’ll cover a sample of the drug companies with funding announcements ...

Read More
Massachusetts Biotech Funding in June 2019
Massachusetts Biotech Funding in June 2019
15 Oct, 2019
Industry Articles
by Sean Cannon

Welcome to the newest segment of our Flagged Events series, Flagged Events: Funding. We’ll cover the drug companies with funding ...

Read More
Discovering Biotech Startups: A map for Selling to Ignite Biosciences
Discovering Biotech Startups: A map for Selling to Ignite Biosciences
15 Oct, 2019
Industry Articles
by David Wilkerson

We hope that you’re enjoying the new branch of our Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology companies ...

Read More
Building your Sales Software Stack: Don't get Lost in the Noise
Building your Sales Software Stack: Don't get Lost in the Noise
15 Oct, 2019
Industry Articles
by Sean Cannon

The sheer number of available tools and solutions that saturate the market is enough to make your head spin. What’s even more staggering is ...

Read More
California Biotech Funding in July 2019
California Biotech Funding in July 2019
15 Oct, 2019
Industry Articles
by Sean Cannon

Welcome to the newest instalment of Flagged Events: Funding segment. We’ll cover a sample of the drug companies with funding announcements ...

Read More
Anything but Generic: A map for Selling to Teva Pharmaceuticals
Anything but Generic: A map for Selling to Teva Pharmaceuticals
15 Oct, 2019
Industry Articles
by Xhermi Trimi

Teva Pharmaceutical Industries Ltd. is an Israeli multinational company headquartered in Petah Tikva, Israel. Teva (meaning "Nature" in ...

Read More
Sponsor Pipeline Insights: The Most Active Drug Companies in Japan
Sponsor Pipeline Insights: The Most Active Drug Companies in Japan
15 Oct, 2019
Industry Articles
by Sean Cannon

Welcome back to Sponsor Pipeline Insights, where we pick regions around the world and examine the most active clinical study registrants. ...

Read More
5 Sales Prospecting Tactics that Work for Biotech and Pharma Professionals
5 Sales Prospecting Tactics that Work for Biotech and Pharma Professionals
15 Oct, 2019
Industry Articles
by Pete Bastedo

Prospecting is typically a dreaded part of the sales process. It goes something like this: Identify target companies. Search LinkedIn to ...

Read More
Discovering Biotech Startups: A map for Selling to Virogenics
Discovering Biotech Startups: A map for Selling to Virogenics
15 Oct, 2019
Industry Articles
by David Wilkerson

We are well on our way with the new branch of the Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology companies ...

Read More
Prospect Viscosity
Prospect Viscosity
15 Oct, 2019
Industry Articles
by Pete Bastedo

This article was originally published by Zymewire on 02/07/2014.

Read More
Discovering Biotech Startups: A map for Selling to Deciduous Therapeutics
Discovering Biotech Startups: A map for Selling to Deciduous Therapeutics
15 Oct, 2019
Industry Articles
by David Wilkerson

We hope that you’re still enjoying the new branch of our Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology ...

Read More
Can I still cold email European pharma companies under GDPR?
Can I still cold email European pharma companies under GDPR?
15 Oct, 2019
Industry Articles
by Pete Bastedo

The big disclaimer: We’re not lawyers and this should not be considered legal advice. We’re based in Canada (ie. not Europe, but we do ...

Read More
California Biotech Funding in June 2019
California Biotech Funding in June 2019
15 Oct, 2019
Industry Articles
by Sean Cannon

Welcome to the newest instalment of Flagged Events: Funding segment. We’ll cover a sample of the drug companies with funding announcements ...

Read More
Allergan eats Kythera: Karan Therapeutics is born
Allergan eats Kythera: Karan Therapeutics is born
14 Oct, 2019
Industry Articles
by Pete Bastedo

This article was originally published by Zymewire on 10/05/2015.

Read More
Navigating Novo: A Map for Selling to Novo Nordisk
Navigating Novo: A Map for Selling to Novo Nordisk
14 Oct, 2019
Industry Articles
by Xhermi Trimi

Novo Nordisk is a Danish pharmaceutical company whose products are marketed in over 165 countries [1]. The company has specialized in ...

Read More
Started From Aspirin™, Now They’re Here: A map for Selling to Bayer
Started From Aspirin™, Now They’re Here: A map for Selling to Bayer
14 Oct, 2019
Industry Articles
by Xhermi Trimi

In the latest edition of our Sponsor Atlas: Selling to the Pharma Giants series, we’re heading to Leverkusen, Germany to take a look at ...

Read More

Custom built for biotech and pharma

We are obsessed with finding new ways to help your business generate more qualified leads. Our human-verified AI scans thousands of documents every day, separates the signal from the noise, and delivers value in the form of actionable sales intelligence.

Demo Zymewire
zymewire-inverted

©2024 Zymewire Logo Trademark of Zymewire, a Division of Lumerate Inc. All rights reserved. Salesforce, Sales Cloud, and others are trademarks of salesforce.com, Inc. and are used here with permission.